
Cancer research has focused on the cancer cell, its proliferation rates, apoptosis resistance, mutation rates, sensitivity to radio and chemotherapy. However, tumor metastatic progression involves many other cellular and molecular players, the tumor microenvironment (TME). In the battle against cancer, to improve the survival and quality of life of metastatic patients, the key cancer supporting players must be identified and targeted. For a tumor to leave its primary site, it must invade the surrounding extracellular matrix, enter the blood or lymphatic circulation, survive in circulation, extravasate at the metastatic site, start proliferating in this new tissue, and during the entire process evade the immune system. In many instances, cancer cells co-opt physiologic niches and processes to survive and even thrive in hostile environments. This is not addressed in 2D monotypic cancer cell cultures. This collection aims to highlight the latest techniques in TME research and promote “multi-cellular” interdisciplinary approaches in the field of metastasis. The collection will cover but is not limited to:
- 3D co-culture methods of cancer and supporting cells and matrices (culture and imaging, e.g. Single Plane Illumination Microscopy)
- tumor microenvironment metabolomic studies
- tumor vasculature imaging techniques (animal models of angiogenesis, multiphoton confocal microscopy of vascularized primary tumors and metastases)
- immune cell modulation and exploitation by cancer cells (flow cytometry methods, adoptive transfer models, intra-vital microscopy)
- circulating and disseminating tumor cell (CTC and DTC) detection methods (including methods to detect the potential of dormant DTCs to reactivate)
- humanized and patient-derived animal models of metastasis and pre-metastatic niches.
0 Views
•
Cited by 49
•
2021
•
1Department of Cellular and Molecular Medicine, University of Arizona, Tucson, 2National University Cancer Institute Singapore, National University Health System, Singapore, 3Cancer Science Institute of Singapore, National University of Singapore, 4Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore
0 Views
•
Cited by 19
•
2021
•
0 Views
•
Cited by 5
•
2020
•
David Jelinek1,2, Ellen Ran Zhang1,2,3, Aaron Ambrus1,2, Erin Haley3, Emily Guinn1,2, Austin Vo1,2, Peter Le1,2, Ayse Elif Kesaf1,2, Jennifer Nguyen1,2, Lily Guo1,2, Destiny Frederick1,2, Zhengyang Sun1,2, Natalie Guo3, Parker Sevier1,2, Eric Bilotta1,2, Kaiser Atai1,2,4, Laurent Voisin1,2, Hilary A. Coller1,2,4
1Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, 2Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, 3Department of Molecular Biology, Princeton University, 4Molecular Biology Institute, University of California, Los Angeles
0 Views
•
Cited by 4
•
2020
•
Margaret A. Nagai-Singer1, Alissa Hendricks-Wenger1,2,3, Rebecca M. Brock1,2, Holly A. Morrison1, Juselyn D. Tupik1, Sheryl Coutermarsh-Ott1, Irving C. Allen1,2,4
1Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, 2Graduate Program in Translational Biology, Medicine and Health, Virginia Polytechnic Institute and State University, 3Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, 4Department of Basic Science Education, Virginia Tech Carilion School of Medicine, Virginia Polytechnic Institute and State University
0 Views
•
Cited by 10
•
2020
•
0 Views
•
Cited by 9
•
2021
•
Florian Bürtin1, Stephanie Matschos2, Friedrich Prall3, Christina S. Mullins2, Mathias Krohn2, Michael Linnebacher2
1Department of General, Visceral, Vascular and Transplantation Surgery, University Medical Center Rostock, University of Rostock, 2Molecular Oncology and Immunotherapy, Department of General, Visceral, Vascular and Transplantation Surgery, University Medical Center Rostock, 3Institute of Pathology, University Medical Center Rostock
0 Views
•
Cited by 12
•
2021
•
0 Views
•
Cited by 15
•
2021
•
Rüdiger Braun1, Olha Lapshyna1, Susanne Eckelmann2,3, Kim Honselmann1, Louisa Bolm1, Meike ten Winkel1, Steffen Deichmann1, Oliver Schilling4, Charli Kruse2,3, Tobias Keck1, Ulrich Wellner1, Peter Bronsert4,5,6, Matthias Brandenburger3
1Department of Surgery, University Medical Center Schleswig-Holstein, 2Institute of Medical and Marine Biotechnology, University of Lübeck, 3Fraunhofer Research and Development Center for Marine and Cellular Biotechnology, 4Institute for Surgical Pathology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, 5Tumorbank Comprehensive Cancer Center Freiburg, Medical Center - University of Freiburg, 6Core Facility Histopathology and Digital Pathology Freiburg, Medical Center - University of Freiburg